ModAstera provides MAEA ("Maya") to automate AI model development for medical applications, reducing time-to-deploy from months to days and cutting costs by up to 90%.
Our Mission
To empower healthtech innovators by providing an easy-to-use, integrated AI platform that reduces development costs, simplifies workflows, and ensures compliance with healthcare regulations, enabling them to deliver transformative solutions and improve global healthcare outcomes.
Our Vision
Be the platform and infrastructure that powers the world's medical AI.
Corporate Profile
NextGeneration Platform to Power the World's Medical AI
All-in-one AI platform for healthtech
Integrates data prep, annotation, model training, and deployment in one workflow.
For beginners & experts
Low-code / no-code UI plus full-code option; cuts cost, complexity, and time-to-market.
Built-in compliance
HIPAA, APPI, and other healthcare regulations baked in for secure, seamless adoption.
Healthcare-specific models
Ready-to-use templates for imaging, diagnostics, patient monitoring, and personalized medicine.
Continuous improvement
Real-time monitoring and adaptive tools keep models effective as data drifts.
Meet Our Team
Our team consists of passionate AI engineers, data scientists and visionaries passionate about revolutionizing healthcare through innovative technology. Leveraging advanced machine learning, data analytics, and cutting-edge technology, we strive to create innovative solutions that enhance patient care and streamline healthcare processes.
Our History
ModAstera, Inc. was selected for the FY2025 Beyond JAPAN On-Site Program, Deep Tech (Bio & Health Tech) Course in San Diego.
ModAstera, Inc. releases MAEA ("Maya"), the world's first Medical AI Engineering Agent.
ModAstera, Inc. was selected as part of the 15 companies in Asia-Pacific region to participate in the Qualcomm AI Program for Innovators.
ModAstera, Inc. won the Takeoff Tokyo 2025 Startup Competition, among over 300 participating companies.
ModAstera, Inc. was incorporated in Tokyo, Japan.
The team received the pre-seed funding from Antler Japan.
Our founders Joshua Owoyemi and Tetsuro Mori met at the Antler Japan Cohort 3 Accelerator program.